A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors

Title
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors
Authors
Keywords
-
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 68, Issue 4, Pages 959-970
Publisher
Springer Nature
Online
2011-02-08
DOI
10.1007/s00280-011-1565-4

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now